Regeneron Pharmaceuticals (REGN) Cash from Operations Growth (1y) (2010 - 2026)

Regeneron Pharmaceuticals (REGN) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Oculis Holding AG 66,440.76 Bn 66,440.47 Bn - 7.14%
2 Nanobiotix 1,880.51 Bn 1,880.45 Bn - -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
4 BeOne Medicines 467.94 Bn 463.15 Bn 1.35 Bn 356.73%
5 Vertex Pharmaceuticals 122.63 Bn 115.38 Bn 2.59 Bn 74.39%
6 Regeneron Pharmaceuticals 70.30 Bn 61.54 Bn 3.31 Bn 3.23%
7 Belite Bio 62.81 Bn 62.81 Bn - -
8 Argenx Se 55.78 Bn 50.59 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.33 Bn 34.32 Bn 959.66 Mn 158.60%
10 Revolution Medicines 37.26 Bn 37.26 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.23%
Dec 31, 2025 -7.29%
Sep 30, 2025 25.36%
Jun 30, 2025 223.28%
Mar 31, 2025 -30.90%
Dec 31, 2024 15.89%
Sep 30, 2024 15.88%
Jun 30, 2024 -65.38%
Mar 31, 2024 10.60%
Dec 31, 2023 -36.64%
Sep 30, 2023 77.18%
Jun 30, 2023 81.15%
Mar 31, 2023 -34.93%
Dec 31, 2022 -27.51%
Sep 30, 2022 -81.58%
Jun 30, 2022 -9.94%
Mar 31, 2022 214.39%
Dec 31, 2021 92.73%
Sep 30, 2021 1,442.35%
Jun 30, 2021 -33.57%